Newsletter

Biotech

Random
A woman standing near a train wearing a face mask due to the SARS-CoV-2 pandemic. Vaccine candidates for COVID-19 such as IBIO-200, in development by iBio, may lead to the end of the pandemic.

iBio COVID-19 Vaccine Program: Latest Updates and Timeline

A person holding a test for the coronavirus that causes COVID-19.

Altimmune To Initiate Phase 1/2 Clinical Trial of COVID-19 Therapy T-COVID

A man grasping a microscope.

FDA Accepts IND Application for Agenus’ iNKT Therapy agenT-797

A man holding a syringe and a vial of medication.

Dupilumab for Eosinophilic Esophagitis: “Pivotal Data” in Phase 3 Trial

Red, white, and yellow pills resting on a pink surface.

JAK1 Inhibitor Filgotinib Shows Efficacy in Treatment of Psoriatic Arthritis

A physician holding a syringe.

CAR-T Therapy Yescarta Leads to High Response Rate in Non-Hodgkin Lymphoma

A man holding an electrified string.

Seneca Biopharma: Phase 3 Trial of Stem Cell Therapy NSI-566 for...

Four syringes resting on a blue surface.

Jounce Presents Preclinical Data for LILRB2 Inhibitor JTX-8064

A person holding a laboratory test for the coronavirus that causes COVID-19.

Altimmune Partners with UAB to Develop Intranasal COVID-19 Vaccine

Cancer researchers standing in a laboratory.

Nkarta Reports First-in-Human Infusion of NKX101 for Acute Myeloid Leukemia

123...5Page 1 of 5

Contact

Connect

Follow Us

ImmunoFrontiers © 2019-2021. All Rights Reserved. We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites. As an Amazon Associate we earn from qualifying purchases.

error: Content is protected.